Before sentencing three Purdue Pharma executives next month, U. District Judge James Jones will consider responses to 16 questions he recently submitted to federal prosecutors and company officials.
As noted by an August 20, 2009 Medill Reports article, "In July, an advisory panel recommended to the FDA the ban of the painkillers Vicodin and Percocet.
A month later, one thing the experts still haven't recommended is an alternative" ("Docs Cringe at the Thought of Painkillers Taken Off the Market").
Additionally, "On June 30, another FDA advisory panel recommended reducing a single adult dose of any acetaminophen from 1,000 milligrams to 650 milligrams - and making Tylenol available by prescription only." The recommendations resulted both from the panel's concerns about the prescription pain relievers' addictive properties as well as the effect of one of their active ingredients, acetaminophen, on users livers.
However, the doctors with whom Medill, an arm of Northwestern University, seem relatively united against the recommendations, questioning both the panels' major concerns: addiction and liver damage.
Medill claimes that "Even more than concerns about addiction, experts question the effect of opiod[sic]/acetaminophen compounds - commonly found in painkillers - on the liver." The article reports that "some doctors" thus "have mixed feelings about the possible ban;" Dr.